Tazolol

Tazolol
Identifiers

CAS Number	39832-48-9
ATC code	None
PubChem	CID 71721
ChemSpider	64770
UNII	B64Q38TX4G^Y
Chemical data
Formula	C₉H₁₆N₂O₂S
Molar mass	216.30 g·mol⁻¹

Tazolol is a beta blocker with some utility in the treatment of heart disease.^[1]

References

↑ Strosberg AM. (1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Arch Int Pharmacodyn Ther. 222 (2): 200–15. PMID 010864.

Sympatholytic (and closely related) antihypertensives (C02)

Sympatholytics
(antagonize α-adrenergic
vasoconstriction)

Central

α₂ agonist	Clonidine Guanabenz Guanfacine Methyldopa^# Tiamenidine^‡

Adrenergic release inhibitors	Bethanidine Bretylium Debrisoquine Guanadrel Guanazodine Guanethidine Guanoclor Guanazodine Guanoxabenz Guanoxan

Imidazoline receptor agonist	Moxonidine Rilmenidine

Ganglion-blocking/nicotinic antagonist	Hexamethonium^‡ Mecamylamine Pentolinium Trimethaphan

Peripheral

Indirect

MAOI	Pargyline^‡

Adrenergic uptake inhibitor	Bietaserpine Deserpidine Methoserpidine Rescinnamine Reserpine

Tyrosine hydroxylase inhibitor	Metirosine

Direct

α₁ blockers	Prazosin Indoramin Trimazosin Doxazosin Urapidil

Non-selective α blocker	Phentolamine

Other antagonists

Serotonin antagonist	Ketanserin Lidanserin

Endothelin antagonist (for PH)	dual (Bosentan, Macitentan) selective (Ambrisentan, Sitaxentan)

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the Saturday, February 06, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

Tazolol

See also

References